Search Results - Vojtech Petr
- Showing 1 - 5 results of 5
-
1
-
2
12-Month Outcomes of a Prospective Randomized Trial Investigating Effects of IVIG on Top of rATG Versus rATG Alone in Pre-Sensitized Kidney Transplant Recipients: The INHIBIT Study by Ondrej Viklicky, Ondrej Viklicky, Ivan Zahradka, Jan Mares, Janka Slatinska, Alena Parikova, Vojtech Petr, Matej Roder, Katerina Jaklova, Klara Osickova, Libor Janousek, Petra Hruba
Published in Transplant International (2025-05-01)Get full text
Article -
3
Acute Kidney Injury in Deceased Organ Donors: Risk Factors And Impacts on Transplantation Outcomes by Katarina Jakubov, MD, Vojtech Petr, MD, Ivan Zahradka, MD, Eva Girmanova, MSc, Petra Hruba, PhD, Roman Keleman, MSc, Ondrej Viklicky, MD, PhD
Published in Transplantation Direct (2024-12-01)Get full text
Article -
4
Composition of peripheral blood immune cell compartment in stage 5 chronic kidney disease is affected by smoking and other risk factors associated with systemic inflammatory respon... by Ivan Zahradka, Filip Tichanek, Lucia Majercikova, Jana Duskova, Mathias Streitz, Stephan Schlickeiser, Stephan Schlickeiser, Klara Osickova, Vojtech Petr, Petra Hruba, Petra Reinke, Ondrej Viklicky, Ondrej Viklicky
Published in Frontiers in Immunology (2025-08-01)Get full text
Article -
5
Safety and Immunogenicity of SARS-CoV-2 mRNA Vaccine Booster Doses in Kidney Transplant Recipients: Results of a 12-mo Follow-up From a Prospective Observational Study by Vojtech Petr, MD, Ivan Zahradka, MD, Istvan Modos, PhD, Matej Roder, MSc, Martina Fialova, MSc, Jana Machkova, MSc, Katerina Kabrtova, MSc, Petra Hruba, PhD, Maria Magicova, MD, Antonij Slavcev, MD, PhD, Ilja Striz, MD, PhD, Ondrej Viklicky, MD, PhD
Published in Transplantation Direct (2024-06-01)Get full text
Article